HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Nasal Cavity Cancer

Nasal cavity cancer is a rare form of cancer that originates in the nasal passages, the intricate network of airways responsible for filtering and humidifying the air we breathe. This type of cancer typically develops in the mucous membrane lining the nasal cavity. Symptoms of nasal cavity cancer may include persistent nasal congestion, nosebleeds, pain or pressure in the face, and changes in the sense of smell. As the disease progresses, individuals may experience difficulty breathing, frequent sinus infections, and the development of lumps or growths within the nasal cavity. Diagnosis often involves a combination of imaging tests, such as CT scans and MRIs, along with a biopsy to confirm the presence of cancerous cells. Treatment options vary depending on the stage of the cancer but may include surgery, radiation therapy, and chemotherapy. Due to its relatively low incidence, nasal cavity cancer poses unique challenges in terms of early detection and treatment. Patients diagnosed in the early stages generally have better outcomes, emphasizing the importance of regular check-ups and prompt medical attention for persistent nasal symptoms. As with many cancers, lifestyle factors such as smoking and exposure to certain occupational hazards may contribute to an increased risk of developing nasal cavity cancer. Therefore, adopting a healthy lifestyle and minimizing exposure to potential risk factors can play a role in prevention. In conclusion, nasal cavity cancer is a rare but serious condition that requires prompt diagnosis and comprehensive treatment. Increased awareness of symptoms and risk factors, along with regular medical check-ups, can contribute to early detection and improved outcomes for individuals affected by this uncommon form of cancer.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp